Eastside Distilling Inc. (EAST)
NASDAQ: EAST
· Real-Time Price · USD
0.89
0.01 (1.25%)
At close: Jan 24, 2025, 3:56 PM
Company Description
Eastside Distilling, Inc. manufactures, acquires, blends, bottles, imports, exports, markets, and sells various alcoholic beverages.
It operates through two segments, Spirits and Craft Canning and Bottling.
The company provides whiskey under the Burnside Whiskey brand; vodka under the Portland Potato Vodka brand; rum under the Hue-Hue Coffee Rum brand; and tequila under the Azuñia Tequila brand.
It also offers gin and ready-to-drink products; and canning and bottling services to the craft beer and cider industries.
The company sells its products on a wholesale basis to distributors in the United States.
Eastside Distilling, Inc. was founded in 2008 and is headquartered in Portland, Oregon.
Eastside Distilling Inc.

Country | United States |
IPO Date | Jan 3, 2017 |
Industry | Beverages - Wineries & Distilleries |
Sector | Consumer Defensive |
Employees | 49 |
CEO | Geoffrey C. Gwin CFA |
Contact Details
Address: 2321 NE Argyle Street Portland, Oregon United States | |
Website | https://www.eastsidedistilling.com |
Stock Details
Ticker Symbol | EAST |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001534708 |
CUSIP Number | 277802302 |
ISIN Number | US2778024016 |
Employer ID | 20-3937596 |
SIC Code | 2080 |
Key Executives
Name | Position |
---|---|
Geoffrey C. Gwin CFA | Chief Executive Officer & Director |
Christopher R. Moe | Chief Financial Officer |
Amy Lancer | Chief Commercial Officer of Spirits |
Joe Ibrahim | Director of Operations |
Stephanie Kilkenny | Company Secretary & Director |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Aug 14, 2025 | 10-Q | Quarterly Report |
Aug 14, 2025 | 8-K | Current Report |
Aug 07, 2025 | PRE 14A | Filing |
Aug 07, 2025 | 8-K | Current Report |
Jul 29, 2025 | 8-K | Current Report |
Jul 29, 2025 | 8-K | Current Report |
Jul 29, 2025 | 8-K | Current Report |
Jul 29, 2025 | 8-K | Current Report |
Jul 24, 2025 | 4/A | [Amend] Filing |
Jul 24, 2025 | SCHEDULE 13D/A | [Amend] Filing |